Cindy Hyde-Smith actually said...

So the FDA, it's more of a legal issue of the procedure that happened than a safety issue of determining what drug is safe.

It is deeply frustrating that the subcommittee is being told--six years after a statutory deadline--that it will be another year before FDA ...

I agree with the fifth circuit's description of this deeply disturbing this of really-not-looking-at-it or the head-in-the-sand approach.

In making its decision to eliminate the in-person dispensing requirement, none of the studies the FDA cited, which were largely conducted by...